Conference item icon

Conference item

NeoSCOPE RTTQA: pre-accrual and on-trial review of all patients in a UK oesophageal RT trial

Abstract:
RTTQA is required to ensure adherence to the outlining and planning aspects of the trial protocol as variations can lead to poorer outcomes. NeoSCOPE, a UK phase II randomized control trial of two neoadjuvant chemoradiotherapy regimens in oesophageal cancer, undertook a comprehensive RTTQA programme with both pre-accrual and prospective on-trial QA of outlining and planning of every patient recruited into the trial.
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1016/S0167-8140(18)31079-X

Authors


Rackley, T More by this author
Radhakrishna, G More by this author
Expand authors...
Publisher:
Elsevier Publisher's website
Volume:
127
Pages:
S397
Publication date:
2018-06-18
Acceptance date:
2018-02-09
DOI:
EISSN:
1879-0887
ISSN:
0167-8140
Pubs id:
pubs:905645
URN:
uri:855c7e36-598e-4fff-8331-15d5d72cdcbb
UUID:
uuid:855c7e36-598e-4fff-8331-15d5d72cdcbb
Local pid:
pubs:905645

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP